Acquisition Strategy Iktos has recently acquired Synsight, a French biotech company, expanding its AI and robotics capabilities in new drug discovery. This acquisition presents an opportunity for cross-selling products and services to Synsight's existing client base.
Partnership Expansion By partnering with Elsevier, a global leader in information and data analytics, Iktos has strengthened its position in artificial intelligence for new drug discovery. Leveraging this partnership, there is a potential to upsell joint solutions to mutual customers of Elsevier and Iktos.
Talent Addition The appointment of Avirup Bose as Chief Business Officer indicates a strategic move by Iktos to enhance its business development efforts. Bose's expertise can be leveraged to drive sales growth by exploring new markets, forming strategic alliances, and leading sales teams effectively.
Sustainability Focus Iktos' collaboration with Bayer's Crop Science division to develop sustainable crop protection products aligns with the growing trend of environmentally friendly solutions. This initiative can open avenues for selling innovative agricultural solutions to environmentally conscious customers.
Recognition & Investment Winning the 'Big Data & AI for Good' prize and securing investments from reputable firms like Omnes Capital showcase Iktos' industry recognition and financial stability. This recognition can boost sales by instilling confidence in potential clients, leading to increased sales opportunities.
1-888-653-2347 
support@leadiq.com 
